Victory Capital Management Inc Roivant Sciences Ltd. Transaction History
Victory Capital Management Inc
- $95.7 Billion
- Q4 2024
A detailed history of Victory Capital Management Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Victory Capital Management Inc holds 27,494 shares of ROIV stock, worth $279,613. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,494
Previous 25,906
6.13%
Holding current value
$279,613
Previous $298,000
9.06%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$669 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$631 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$486 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$448 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$360 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.16B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...